Costa Rica vs Tonga: Burden of disease
Costa Rica
26,321 DALYs per 100,000 people
in 2021
Tonga
26,462 DALYs per 100,000 people
in 2021
Costa Rica rank
167th
Tonga rank
166th
Burden of disease over time
- Costa Rica
- Tonga
How they compare
Tonga currently reports 26,462 DALYs per 100,000 people against 26,321 DALYs per 100,000 people in Costa Rica, a difference of 141 DALYs per 100,000 people.
Across all 22 years both countries report, Tonga has been ahead every year.
Costa Rica ranks 167th and Tonga ranks 166th of 194 countries.
Tonga has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20,659 DALYs per 100,000 people | 27,086 DALYs per 100,000 people | 6,427 DALYs per 100,000 people | Tonga |
| 2010s | 22,160 DALYs per 100,000 people | 26,145 DALYs per 100,000 people | 3,985 DALYs per 100,000 people | Tonga |
| 2020s | 25,188 DALYs per 100,000 people | 26,120 DALYs per 100,000 people | 932.3 DALYs per 100,000 people | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher burden of disease, Costa Rica or Tonga?
- Tonga, at 26,462 DALYs per 100,000 people against 26,321 DALYs per 100,000 people in Costa Rica as of 2021.
- What is the difference in burden of disease between Costa Rica and Tonga?
- 141 DALYs per 100,000 people, with Tonga ahead.
- How many years of comparable data are there for Costa Rica and Tonga?
- 22 years are reported by both, from 2000 to 2021.
- How do Costa Rica and Tonga rank globally for burden of disease?
- Costa Rica ranks 167th and Tonga ranks 166th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Burden of disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of DALYs from all causes in both sexes, per 100,000 people.